FDA Approves First Gene Therapy for Deafness

The U.S. Food and Drug Administration has approved the first gene therapy for a rare form of deafness, offering a new treatment that has enabled children with the condition to hear.

23 Apr, 17:20 — 23 Apr, 20:46

Post Share

Why this matters

This approval represents a monumental advancement in gene therapy and the treatment of sensory disorders, offering hope to individuals with congenital deafness. It opens new avenues for therapeutic interventions in genetic conditions previously considered untreatable, potentially improving the quality of life for many.

Key entitiesFDA Regeneron

The Story

What 3 sources agree on, dispute, and miss

What sources agree on

The FDA has approved the first gene therapy for deafness
The therapy is designed for a rare form of congenital deafness
The treatment can restore hearing

Key claims2 agreed · 1 unverified

✓

The FDA approved the first gene therapy for deafness.

agreed·NPRNYTseeking-alpha

✓

The therapy can restore hearing to people born with a rare form of deafness.

agreed·NPRNYT

Regeneron developed the approved hearing loss therapy.

unverified·seeking-alpha

Coverage gaps

Specific details about the company behind the therapy (Regeneron)

Reportedseeking-alpha

MissingNPRNYT

Personal testimony from a parent about their child's restored hearing

ReportedNYT

MissingNPRseeking-alpha

The Story

Analyzing sources…

Source Diversity

Moderate (46/100)

3 sources25/33

Spectrum spread— 3/5 buckets covered17/33

Far L1

Far Left (1)

NYT

Left1

Left (1)

NPR

Center

Right1

Right (1)

seeking-alpha

Far R

Geographic diversity— 1 region4/34

US3

ℹAll sources from US region

Sources

Showing 3 of 3 sources

NYTMostly Factual3h ago

New Gene Therapy Enables Children With a Rare Form of Deafness to Hear

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.

By Gina Kolata

Read full article →

NPRHigh36m ago